Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome

被引：0
|
作者：
Che-Hung Lin
Su-Peng Yeh
Tze-Yi Lin
机构：
[1] China Medical University Hospital,Division of Hematology and Oncology, Department of Internal Medicine
[2] China Medical University Hospital,Stem Cell Research Lab., Department of Medical Research
[3] China Medical University,undefined
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Skin Lesion; Myelodysplastic Syndrome; Allogeneic Stem Cell Transplantation; Azacitidine; Panniculitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1925 / 1926
页数：1
相关论文
共 50 条
  • [1] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [2] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [3] Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin
    Limaye, Sewanti
    Lipshitz, Jay
    Dulala, Renuka
    Patel, Dilip
    [J]. BLOOD, 2007, 110 (11) : 230B - 230B
  • [4] Ulcerative Sweet syndrome accompanied by interstitial lung disease and myelodysplastic syndrome
    Xu, Hong-Hui
    Xiao, Ting
    Gao, Xing-Hua
    Chen, Hong-Duo
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (04) : 411 - 412
  • [5] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [6] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    [J]. BLOOD, 2011, 118 (21) : 745 - 746
  • [7] Azacitidine (Vidaza) for myelodysplastic syndrome
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1201): : 11 - 11
  • [8] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
  • [9] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
    Kantarjian, HM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416
  • [10] Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
    Kaminskas, E
    Farrell, A
    Abraham, S
    Baird, A
    Hsieh, LS
    Lee, SL
    Leighton, JK
    Patel, H
    Rahman, A
    Sridhara, R
    Wang, YC
    Pazdur, R
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3604 - 3608
12345